Press Releases

Press Releases

Finch Therapeutics Provides Corporate Updates and Reports Third Quarter 2022 Financial Results
Finch Therapeutics to Present at the Jefferies London Healthcare Conference and Evercore ISI HealthCONx Conference
Finch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022 and Proceeds with Patient Dosing in Phase 3 Trial of CP101 in Recurrent C. Difficile Infection
Finch Therapeutics Regains Full Rights to FIN-524 and FIN-525 Targeted Microbiome Product Candidates in Development for IBD
Finch Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results
Finch Therapeutics to Participate in Upcoming June Investor Conferences
Finch Therapeutics to Present at the H.C. Wainwright Global Investment Conference
Finch Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
Finch Therapeutics to Host Corporate Update Conference Call and Webcast on May 16, 2022
Displaying 1 - 10 of 18